Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wonnacott

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|July 1, 2008
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's DiseaseJ Andrés Abin-Carriquiry, Gustavo Costa, Jessika Urbanavicius, et al.
European Journal of Pharmacology|February 27, 2010
Increase in locomotor activity after acute administration of the nicotinic receptor agonist 3-bromocytisine in ratsJuan Andrés Abin-Carriquiry, Jessika Urbanavicius, Cecilia Scorza, et al.
Journal of Neurochemistry|September 14, 2012
Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytesHayley M Bennett, Kristin Lees, Kate M Harper, et al.
The European Journal of Neuroscience|February 4, 2009
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortexPhil D Livingstone, Jayaraman Srinivasan, James N C Kew, et al.
Structure (London, England : 1993)|May 28, 2019
Identification of the Initial Steps in Signal Transduction in the α4β2 Nicotinic Receptor: Insights from Equilibrium and Nonequilibrium SimulationsA Sofia F Oliveira, Deborah K Shoemark, Hugo Rego Campello, et al.
Vaccine|September 18, 2007
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategiesJennifer L Oliver, Ghazaleh Pashmi, Paul Barnett, et al.
Journal of Medicinal Chemistry|July 12, 2002
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165Christopher G V Sharples, Gunter Karig, Graham L Simpson, et al.
European Journal of Pharmacology|March 28, 2006
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonistsJ Andrés Abin-Carriquiry, Merja H Voutilainen, Jacques Barik, et al.
Molecular Pharmacology|June 16, 2010
Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptorsPatricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 1, 2011
Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulationLaura Del Barrio, María Dolores Martín-de-Saavedra, Alejandro Romero, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|July 1, 2008
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's DiseaseJ Andrés Abin-Carriquiry, Gustavo Costa, Jessika Urbanavicius, et al.
European Journal of Pharmacology|February 27, 2010
Increase in locomotor activity after acute administration of the nicotinic receptor agonist 3-bromocytisine in ratsJuan Andrés Abin-Carriquiry, Jessika Urbanavicius, Cecilia Scorza, et al.
Journal of Neurochemistry|September 14, 2012
Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytesHayley M Bennett, Kristin Lees, Kate M Harper, et al.
The European Journal of Neuroscience|February 4, 2009
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortexPhil D Livingstone, Jayaraman Srinivasan, James N C Kew, et al.
Structure (London, England : 1993)|May 28, 2019
Identification of the Initial Steps in Signal Transduction in the α4β2 Nicotinic Receptor: Insights from Equilibrium and Nonequilibrium SimulationsA Sofia F Oliveira, Deborah K Shoemark, Hugo Rego Campello, et al.
Vaccine|September 18, 2007
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategiesJennifer L Oliver, Ghazaleh Pashmi, Paul Barnett, et al.
Journal of Medicinal Chemistry|July 12, 2002
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165Christopher G V Sharples, Gunter Karig, Graham L Simpson, et al.
European Journal of Pharmacology|March 28, 2006
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonistsJ Andrés Abin-Carriquiry, Merja H Voutilainen, Jacques Barik, et al.
Molecular Pharmacology|June 16, 2010
Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptorsPatricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 1, 2011
Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulationLaura Del Barrio, María Dolores Martín-de-Saavedra, Alejandro Romero, et al.
Pageof 7